PROSTATE CANCER METASTATIC

Clinical trials for PROSTATE CANCER METASTATIC explained in plain language.

Never miss a new study

Get alerted when new PROSTATE CANCER METASTATIC trials appear

Sign up with your email to follow new studies for PROSTATE CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 1 Not yet finished but already full! 6 Completed 1 Terminated 2

New drug combo tested for Tough-to-Treat prostate cancer

Disease control Completed

This study tested a combination of two drugs, talazoparib and temozolomide, for men with advanced prostate cancer that had spread and stopped responding to standard hormone therapies. The first part of the study aimed to find the safest dose, and the second part tested how well t…

Matched conditions: PROSTATE CANCER METASTATIC

Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

PROSTATE CANCER METASTATIC

Get alerted when new PROSTATE CANCER METASTATIC trials appear

New drug combo tested for Tough-to-Treat prostate cancer